Skip to main content

Good evening, here are the coronavirus updates you need to know tonight.

Top headlines:

  1. Quebec-based biopharmaceutical company Medicago is the first in Canada to advance its vaccine to a large-scale study
  2. As the European Union faces a third wave of the pandemic, it is threatening to ban exports of COVID-19 vaccines to Britain to safeguard scarce doses
  3. The World Health Organization gives its support to the Oxford-AstraZeneca vaccine after more than a dozen European countries suspend its use

In the last 7 days, 22,506 cases were reported, up 6 per cent from the previous 7 days. There were 219 deaths announced, down 5 per cent over the same period. At least 2,020 people are being treated in hospitals and 865,090 others are considered recovered.

About 81 per cent of the 4,213,080 doses of vaccine distributed to provinces have been administered. Canada’s inoculation rate is 36th among 84 countries with a population of one million or more people.

Open this photo in gallery:

Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopeningVaccine distribution planFour vaccines approved in CanadaEssential resources


Photo of the day

Open this photo in gallery:

People show up to the Schaumburg Convention Center for the Pfizer COVID-19 vaccination on Wednesday, March 17, 2021 in Schaumburg, Ill.Mark Welsh/The Associated Press


Coronavirus in Canada


In Ottawa, the national drop in severe COVID-19 outcomes, like hospitalizations and deaths, is beginning to level off and the average number of daily new cases is on the rise again, Canada’s top doctor said today.

  • On average, over the last seven days, 2,048 people with COVID-19 were being treated in Canadian hospitals every day, including 550 people in ICU. Infection rates are highest among those between the ages of 20 and 39.

Medicago: Quebec-based biopharmaceutical company Medicago Inc. is moving forward with its Phase 3 clinical trial, currently aiming to enroll 30,000 participants from 10 countries, including Canada, the United States and Britain.

Worker protection: Advocates for migrant workers are pushing for stronger COVID-19 protections.


Coronavirus around the world


Coronavirus and business

Atlantic Canada premiers are planning on discussing reopening the “Atlantic bubble” – allowing East Coast businesses to salvage the tourism season this summer.

  • The bigger question is when travellers from other parts of the country might be allowed in without restrictions.
  • One of Atlantic Canada’s most prominent epidemiologists says it’s too early to know how the vaccine rollout may evolve, and what the risk of allowing outside visitors would be.
  • Susan Kirkland, chief of the department of community health and epidemiology at Dalhousie University, suggests even fully vaccinated travellers from Ontario or Quebec hoping to visit this summer should still plan on a 14-day quarantine period when they arrive.

Also today: Global oil demand is unlikely to return to its pre-COVID-19 growth rate, a new report says.

And: Canada’s inflation rate edged higher, setting the stage for a jump in the coming months.


Globe opinion


More reporting

  • Basketball: Toronto Raptor Fred VanVleet says the blame and guilt associated with COVID-19 is unfair
  • Health and fitness: Hok skis, a hybrid of cross-country skis and snowshoes, can help people get outside and beat the pandemic blues

Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? Email us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe